183 related articles for article (PubMed ID: 19685371)
1. Nephrotoxicity associated with the use of intravenous colistin.
Santamaría C; Mykietiuk A; Temporiti E; Stryjewski ME; Herrera F; Bonvehi P
Scand J Infect Dis; 2009; 41(10):767-9. PubMed ID: 19685371
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of colistin (colistimethate sodium) for therapy of infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii in Siriraj Hospital, Bangkok, Thailand.
Koomanachai P; Tiengrim S; Kiratisin P; Thamlikitkul V
Int J Infect Dis; 2007 Sep; 11(5):402-6. PubMed ID: 17291803
[TBL] [Abstract][Full Text] [Related]
3. Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii.
Levin AS; Barone AA; Penço J; Santos MV; Marinho IS; Arruda EA; Manrique EI; Costa SF
Clin Infect Dis; 1999 May; 28(5):1008-11. PubMed ID: 10452626
[TBL] [Abstract][Full Text] [Related]
4. Nephrotoxicity associated with intravenous colistin in critically ill patients.
Doshi NM; Mount KL; Murphy CV
Pharmacotherapy; 2011 Dec; 31(12):1257-64. PubMed ID: 22122186
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of intravenous colistin (colistin methanesulphonate) for severe multidrug-resistant Gram-negative bacterial infections.
Cheng CY; Sheng WH; Wang JT; Chen YC; Chang SC
Int J Antimicrob Agents; 2010 Mar; 35(3):297-300. PubMed ID: 20045293
[TBL] [Abstract][Full Text] [Related]
6. Nephrotoxicity of intravenous colistin: a prospective evaluation.
Falagas ME; Fragoulis KN; Kasiakou SK; Sermaidis GJ; Michalopoulos A
Int J Antimicrob Agents; 2005 Dec; 26(6):504-7. PubMed ID: 16280245
[TBL] [Abstract][Full Text] [Related]
7. Toxicity after prolonged (more than four weeks) administration of intravenous colistin.
Falagas ME; Rizos M; Bliziotis IA; Rellos K; Kasiakou SK; Michalopoulos A
BMC Infect Dis; 2005 Jan; 5():1. PubMed ID: 15642116
[TBL] [Abstract][Full Text] [Related]
8. Intravenous colistin sulphomethate sodium for therapy of infections due to multidrug-resistant gram-negative bacteria.
Pintado V; San Miguel LG; Grill F; Mejía B; Cobo J; Fortún J; Martín-Dávila P; Moreno S
J Infect; 2008 Mar; 56(3):185-90. PubMed ID: 18280570
[TBL] [Abstract][Full Text] [Related]
9. Intravenous and inhalational colistin-induced respiratory failure.
Wahby K; Chopra T; Chandrasekar P
Clin Infect Dis; 2010 Mar; 50(6):e38-40. PubMed ID: 20146630
[TBL] [Abstract][Full Text] [Related]
10. Colistin and rifampicin combination in the treatment of ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii.
Song JY; Lee J; Heo JY; Noh JY; Kim WJ; Cheong HJ; Hwang IS
Int J Antimicrob Agents; 2008 Sep; 32(3):281-4. PubMed ID: 18650070
[No Abstract] [Full Text] [Related]
11. Clinical characteristics and risk factors of colistin-induced nephrotoxicity.
Kim J; Lee KH; Yoo S; Pai H
Int J Antimicrob Agents; 2009 Nov; 34(5):434-8. PubMed ID: 19726164
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for colistin-associated nephrotoxicity.
Rattanaumpawan P; Ungprasert P; Thamlikitkul V
J Infect; 2011 Feb; 62(2):187-90. PubMed ID: 21129401
[No Abstract] [Full Text] [Related]
13. Parenteral and inhaled colistin for treatment of ventilator-associated pneumonia.
Linden PK; Paterson DL
Clin Infect Dis; 2006 Sep; 43 Suppl 2():S89-94. PubMed ID: 16894521
[TBL] [Abstract][Full Text] [Related]
14. Intravenous colistin sulfate: a rarely used form of polymyxin E for the treatment of severe multidrug-resistant Gram-negative bacterial infections.
Huang J; Tang YQ; Sun JY
Scand J Infect Dis; 2010 Apr; 42(4):260-5. PubMed ID: 20085424
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness and nephrotoxicity of colistin monotherapy vs. colistin-meropenem combination therapy for multidrug-resistant Gram-negative bacterial infections.
Falagas ME; Rafailidis PI; Kasiakou SK; Hatzopoulou P; Michalopoulos A
Clin Microbiol Infect; 2006 Dec; 12(12):1227-30. PubMed ID: 17121631
[TBL] [Abstract][Full Text] [Related]
16. Nephrotoxicity associated with intravenous colistin.
Tarchini G
Clin Infect Dis; 2009 Dec; 49(11):1773; author reply 1773. PubMed ID: 19891573
[No Abstract] [Full Text] [Related]
17. [The revival of colistin: an old antibiotic for the 21st century].
Nasnas R; Saliba G; Hallak P
Pathol Biol (Paris); 2009 May; 57(3):229-35. PubMed ID: 18178335
[TBL] [Abstract][Full Text] [Related]
18. Incidence of and risk factors for colistin-associated nephrotoxicity in a large academic health system.
Pogue JM; Lee J; Marchaim D; Yee V; Zhao JJ; Chopra T; Lephart P; Kaye KS
Clin Infect Dis; 2011 Nov; 53(9):879-84. PubMed ID: 21900484
[TBL] [Abstract][Full Text] [Related]
19. Emergent renal dysfunction with colistin pharmacotherapy.
Collins JM; Haynes K; Gallagher JC
Pharmacotherapy; 2013 Aug; 33(8):812-6. PubMed ID: 23606349
[TBL] [Abstract][Full Text] [Related]
20. Nephrotoxicity associated with intravenous colistin (colistimethate sodium) treatment at a tertiary care medical center.
Hartzell JD; Neff R; Ake J; Howard R; Olson S; Paolino K; Vishnepolsky M; Weintrob A; Wortmann G
Clin Infect Dis; 2009 Jun; 48(12):1724-8. PubMed ID: 19438394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
